CHARCOT-MARIE-TOOTH SUBTYPE BIOMARKERS AND OUTCOME MEASURES IN SUBJECTS WITH CMT1B, CMT2A, CMT2F AND CMT1X

被引:0
|
作者
Dragon, Amanda [1 ]
Reilly, Mary [2 ]
Svaren, John [3 ]
Scherer, Steven [4 ]
Pareyson, Davide [5 ]
Herrmann, David [6 ]
Shy, Michael E. [1 ]
机构
[1] Univ Iowa, Carver Coll Med, Iowa City, IA USA
[2] UCL Queen Sq Inst Neurol, London, England
[3] Univ Wisconsin Madison, Madison, WI USA
[4] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[6] Univ Rochester, Dept Neurol, Rochester, MN USA
关键词
CMT; Charcot-Marie-Tooth; neuropathy;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P 044
引用
收藏
页码:S17 / S18
页数:2
相关论文
共 50 条
  • [21] Linkage mapping and clinico-pathological findings of Charcot-Marie-Tooth disease type 2A (CMT2A)
    Saito, M
    Hayashi, Y
    Suzuki, T
    Tanaka, H
    Tsuji, S
    NEUROLOGY, 1997, 48 (03) : 5094 - 5094
  • [22] THE GERMAN CHARCOT-MARIE-TOOTH DISEASE NETWORK (CMT-NET): DISEASE SEVERITY AND PROGNOSTIC BIOMARKERS FROM BLOOD AND SKIN OF CMT1A PATIENTS
    Prukop, T.
    Garcia-Angarita, N.
    Koenig, L. S.
    Pieper, D.
    Draeger, B.
    Thiele, S.
    Huettemann, D.
    Schlotter-Weigel, B.
    Walter, M. C.
    Young, P.
    Sereda, M. W.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 363 - 364
  • [23] Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine
    Jariwal, Roopam
    Shoua, Basel
    Sabetian, Katayoun
    Natarajan, Piruthiviraj
    Cobos, Everardo
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2018, 6
  • [24] Unilateral oculomotor palsy in Charcot-Marie-Tooth disease lA (CMT 1A)
    Posa, A.
    Emmer, A.
    Kornhuber, M. E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 155 : 20 - 21
  • [25] Charcot-Marie-Tooth (CMT) Disease 1A with Superimposed Inflammatory Polyneuropathy in Children
    Desurkar, A.
    Lin, J. -P.
    Mills, K.
    Al-Sarraj, S.
    Jan, W.
    Jungbluth, H.
    Wraige, E.
    NEUROPEDIATRICS, 2009, 40 (02) : 85 - 88
  • [26] A PROSPECTIVE EVALUATION OF PREGNANT WOMEN WITH CHARCOT-MARIE-TOOTH 1 DISEASE (CMT1)
    Leal, R. C.
    Algemiro, J. B. S.
    Marques, V. D.
    Toscano, P.
    Lourenco, C. M.
    Marques Jr, W.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 180 - 180
  • [27] P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A)
    Nobbio, L.
    Visigalli, D.
    Mannino, E.
    Pareyson, D.
    Sereda, M. W.
    Prada, V
    Mancardi, G.
    Zocchi, E.
    Bruzzone, S.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 80 - 80
  • [28] Clinical presentation in patients with axonal Charcot-Marie-Tooth disease (CMT2)
    Nikodinovic, J.
    Rasic, V. Milic
    Mladenovic, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 232 - 232
  • [29] LINKAGE MAPPING OF CHARCOT MARIE TOOTH NEUROPATHY (CMT1A)
    NICHOLSON, GA
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2008 - 2008
  • [30] RANDOMISED CONTROLLED TRIAL WITH ASCORBIC ACID IN CHARCOT-MARIE-TOOTH TYPE 1A: RESULTS OF THE CMT-TRIAAL/CMT-TRAUK
    Pareyson, D.
    Reilly, M. M.
    Schenone, A.
    Fabrizi, G. M.
    Cavallaro, T.
    Santoro, L.
    Vita, G.
    Quattrone, A.
    Padua, L.
    Gemignani, F.
    Visioli, F.
    Laura, M.
    Calabrese, D.
    Hughes, R. A. C.
    Radice, D.
    Solari, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S104 - S105